In January, ThromboGenics nominated Emmanuele Attout to be its new Independent non-executive director. Mrs. Attout was appointed during the ThromboGenics Annual Shareholders Meeting of May 5, 2015. She will also join the Audit Committee of the Company.

Mrs. Attout has been an audit partner at PricewaterhouseCoopers since 1994. She has been in charge of the audits for a wide range of clients, including in recent years being in charge of the audits of publicly listed pharmaceutical companies and life sciences businesses.